Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Uveal Melanoma 1 Recurrence 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myelomonocytic, Chronic 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Graft vs Host Disease 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

Ipilimumab 3 Triamcinolone Acetonide 2 Ranibizumab 2 Nivolumab 2 Amplified Fragment Length Polymorphism Analysis 2 treosulfan 1 salicylhydroxamic acid 1 aldesleukin 1 Ultrasonography 1 Tramadol 1 Temozolomide 1 Tamoxifen 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Sorafenib 1 Rose Bengal 1 Radiosurgery 1 Physical Examination 1 Pharmacogenomic Testing 1 Interviews as Topic 1 Immunotherapy 1 Ibuprofen 1 Gemcitabine 1 Eye Enucleation 1 Cyclophosphamide 1 Cisplatin 1 Chemotherapy, Adjuvant 1 CTLA-4 Antigen 1 Brachytherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Uveal Melanoma × treosulfan × Clear all

NCT00168870 2007-08-31

Study of Metastatic Ocular Melanoma

Charite University, Berlin, Germany

Phase 2 Unknown

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡